Company Description
Digicann Ventures (OTC Link: AGFAF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $345.8K.
AGFAF stock has declined 67.5% over the past year. Shares last traded at $0.0039.
This page provides a comprehensive overview of AGFAF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Digicann Ventures (AGFAF) stock last traded at $0.0039. Over the past 12 months, the stock has lost 67.5%. At a market capitalization of $345.8K, AGFAF is classified as a micro-cap stock with approximately 23.1M shares outstanding.
Latest News
Digicann Ventures has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 4 with negative movement. View all AGFAF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Digicann Ventures (AGFAF) currently stands at 55.0 thousand shares, up 0.0% from the previous reporting period, representing 0.2% of the float. Over the past 12 months, short interest has increased by 1041.2%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Digicann Ventures (AGFAF) currently stands at 1.1 days, up 6% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 99.9% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
AGFAF Company Profile & Sector Positioning
Digicann Ventures (AGFAF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing AGFAF often look at related companies in the same sector, including Transglobal Asse (TMSH), CuraScientific copr (CSTF), Livewire (LVVV), Lowell Farms (LOWLF), and Greater Cannabis (GCAN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate AGFAF's relative position within its industry.